About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
Logout
Obstetrics and Gynegology2021№3
Endometriosis and cancer

Endometriosis and cancer

DOI
https://dx.doi.org/10.18565/aig.2021.3.12-17

Muftaydinova Sh.K., Buralkina N.A., Faizullin L.Z.

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia
Based on the data of foreign and Russian articles, this review comparatively analyzes the pathogenesis of endometriosis and cancer. It has been established that endometriosis, especially its infiltrative forms, has many properties in common with cancer: uncontrolled growth and multifocal localizations of endometrioid implants, reduced apoptosis, metastasis to the lymph nodes and spread inside and outside the abdominal cavity, penetration into the surrounding tissues, stimulation of non-angiogenesis, as well as chronic inflammation and oxidative stress. The endometrioid implants show genetic and epigenetic mutations involved in oncogenic transformation. Enhanced angiogenesis required for cell growth is the most important sign of a malignant tumor. The same increased level of angiogenic factors is also found in the tissues of deep infiltrative endometriosis. Antiangiogenic therapy effectively suppresses endometrioid tissue growth and reduces pain. Women with endometriosis have an increased incidence of malignant neoplasms, which indicates the similarity of their pathogenesis and common environmental molecular and genetic risk factors.
Conclusion. When aggregating these data, it becomes possible to consider endometriosis in the context of oncogenesis, which opens up new possibilities of drug therapy.

Keywords

endometriosis
cancer
apoptosis
metastasis
Full text (in Russian)

References

  1. The World Bank. Population ages 15–64 (% of total population). World Bank staff estimates based on age/sex distributions of United Nations Population Division's World Population Prospects: 2019 Revision.
  2. Министерство здравоохранения Российской Федерации, Департамент медицинской помощи детям и службы родовспоможения. Основные показатели деятельности акушерско-гинекологической службы в Российской Федерации в 2018 году. Статистический сборник 2018. М.; 2019. [Ministry of Health of the Russian Federation, Department of Child Care and Obstetrics Services. Key performance indicators of the obstetric and gynecological service in the Russian Federation in 2018. Statistical collection 2018. Moscow; 2019. (in Russian)].
  3. Адамян Л.В., Салимова Д.Ф., Кондратович Л.М. Патогенетические аспекты эндометриоз-ассоциированного бесплодия. Проблемы репродукции. 2015; 21(6): 90-6. [Adamyan L.V., Salimova D.F., Kondratovich L.M. Pathogenetic aspects of endometriosis-associated infertility. Problems of reproduction. 2015; 21(6): 90-6. (in Russian)]. https://dx.doi.org/10.17116/ repro201521682-88.
  4. Tanbo T., Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet. Gynecol. Scand. 2017; 96(6): 659-67. https://dx.doi.org/10.1111/aogs.13082.
  5. Zondervan K.T., Becker C.M., Missmer S.A. Endometriosis. N. Engl. J. Med. 2020; 382(13): 1244-56. https://dx.doi.org/10.1056/NEJMra1810764.PMID: 32212520.
  6. Bulun S.E., Yilmaz B.D., Sison C., Miyazaki K., Bernardi L., Liu S. et al. Endometriosis. Endocr. Rev. 2019; 40(4): 1048-79. https://dx.doi.org/10.1210/er.2018-00242.
  7. Адамян Л.В., Фархат К.Н., Макиян З.Н., Савилова А.М. Молекулярно-биологическая характеристика эутопического и эктопического эндометрия (обзор литературы). Проблемы репродукции. 2015; 21(5): 8-16. [Adamyan L.V., Farhat K.N., Makiyan Z.N., Savilova А.М. Molecular-biological characteristics of eutopic and ectopic endometria (literature review). Reproduction problems. 2015; 21(5): 8-16. (in Russian)]. https://dx.doi.org/10.17116/repro20152158-16.
  8. Sampson J. The development of the implantation theory for the origin of peritoneal endometriosis. Am. J. Obstet. Gynecol. 1940; 40: 549-56.
  9. Jerman L.F., Hey-Cunningham A.J. The role of the lymphatic system in endometriosis: a comprehensive review of the literature. Biol. Reprod. 2015; 92(3): 64. https://dx.doi.org/10.1095/biolreprod.114.124313.
  10. Augoulea A., Lambrinoudaki I., Christodoulakos G. Thoracic endometriosis syndrome. Respiration. 2008; 75(1): 113-9. https://dx.doi.org/10.1159/000105102.
  11. Sarma D., Iyengar P., Marotta T.R., terBrugge K.G., Gentili F., Halliday W. Cerebellar endometriosis. AJR Am. J. Roentgenol. 2004; 182(6): 1543-6. https://dx.doi.org/10.2214/ajr.182.6.1821543.
  12. Koninckx P.R., Gomel V., Ussia A., Adamyan L. Role of the peritoneal cavity in the prevention of postoperative adhesions, pain, and fatigue. Fertil. Steril. 2016; 106(5): 998-1010. https://dx.doi.org/10.1016/j.fertnstert.2016.08.012.
  13. Vallvé-Juanico J., Houshdaran S., Giudice L.C. The endometrial immune environment of women with endometriosis. Hum. Reprod. Update. 2019; 25(5): 564-91. https://dx.doi.org/10.1093/humupd/dmz018.
  14. Young V.J., Ahmad S.F., Duncan W.C., Horne A.W. The role of TGF-β in the pathophysiology of peritoneal endometriosis. Hum. Reprod. Update. 2017; 23(5): 548-59. https://dx.doi.org/10.1093/humupd/dmx016.
  15. Wilson R.B. Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis. Pleura Peritoneum. 2018; 3(1): 20180103. https://dx.doi.org/10.1515/pp-2018-0103.
  16. Davis A.C., Goldberg J.M. Extrapelvic endometriosis. Semin. Reprod. Med. 2017; 35(1): 98-101. https://dx.doi.org/10.1055/s-0036-1597122.
  17. Al-Obaidy K.I., Idrees M.T. Endometriosis with cystic degeneration: a rare disease of males. Int. J. Surg. Pathol. 2019; 27(3): 311-4. https://dx.doi.org/10.1177/1066896918797438.
  18. Koninckx P.R., Barlow D., Kennedy S. Implantation versus infiltration: the Sampson versus the endometriotic disease theory. Gynecol. Obstet. Invest. 1999; 47(Suppl. 1): 3-9; discussion 9-10. https://dx.doi.org/10.1159/000052853.
  19. Suginami H. A reappraisal of the coelomic metaplasia theory by reviewing endometriosis occurring in unusual sites and instances. Am. J. Obstet. Gynecol. 1991; 165(1): 214-8.
  20. Troncon J.K., Zani A.C.T., Vieira A.D., Poli-Neto O.B., Nogueira A.A., Rosa-e-Silva J.C. Endometriosis in a patient with Mayer-Rokitansky-Küster-Hauser syndrome. Case Rep. Obstet. Gynecol. 2014; 2014: 376231. https://dx.doi.org/10.1155/2014/376231.
  21. Brosens I., Benagiano G. Is neonatal uterine bleeding involved in the pathogenesis of endometriosis as a source of stem cells? Fertil. Steril. 2013;100(3): 622-3. https://dx.doi.org/10.1016/j.fertnstert.2013.04.046.
  22. Gargett C.E., Schwab K.E., Brosens J.J., Puttemans P., Benagiano G., Brosens I. Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis. Mol. Hum. Reprod. 2014; 20(7): 591-8. https://dx.doi.org/10.1093/molehr/gau025.
  23. Klemmt P.A.B., Starzinski-Powitz A. Molecular and cellular pathogenesis of endometriosis. Curr. Womens Health Rev. 2018; 14(2): 106-16. https://dx.doi.org/10.2174/1573404813666170306163448.
  24. Koninckx P.R., Ussia A., Adamyan L., Wattiez A., Gomel V., Martin D.C. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil. Steril. 2019; 111(2): 327-40. https://dx.doi.org/10.1016/j.fertnstert.2018.10.013.
  25. Wang Y., Nicholes K., Shih I.M. The origin and pathogenesis of endometriosis. Annu. Rev. Pathol. 2020; 15: 71-95. https://dx.doi.org/10.1146/annurev-pathmechdis-012419-032654.
  26. Wilbur M.A., Shih I.M., Segars J.H., Fader A.N. Cancer implications for patients with endometriosis. Semin. Reprod. Med. 2017; 35(1): 110-6. https://dx.doi.org/10.1055/s-0036-1597120.
  27. Pejovic T., Thisted S., White M., Nezhat F.R. Endometriosis and endometriosis-associated ovarian cancer (EAOC). Adv. Exp. Med. Biol. 2020; 1242: 73-87. https://dx.doi.org/10.1007/978-3-030-38474-6_5.
  28. Králíčková M., Laganà A.S., Ghezzi F., Vetvicka V. Endometriosis and risk of ovarian cancer: what do we know? Arch. Gynecol. Obstet. 2020; 301(1): 1-10. https://dx.doi.org/10.1007/s00404-019-05358-8.
  29. Pearce C.L., Templeman C., Rossing M.A., Lee A., Near A.M., Webb P.M. et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol. 2012; 13(4): 385-94. https://dx.doi.org/10.1016/S1470-2045(11)70404-1.
  30. Bulun S.E., Wan Y., Matei D. Epithelial mutations in endometriosis: link to ovarian cancer. Endocrinology. 2019; 160(3): 626-38. https://dx.doi.org/10.1210/en.2018-00794.
  31. Kajiyama H., Suzuki S., Yoshihara M., Tamauchi S., Yoshikawa N., Niimi K. et al. Endometriosis and cancer. Free Radic. Biol. Med. 2019; 133: 186-92. https://dx.doi.org/10.1016/j.freeradbiomed.2018.12.015.
  32. Anglesio M.S., Bashashati A., Wang Y.K., Senz J., Ha G., Yang W. et al. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. J. Pathol. 2015; 236(2): 201‐9. https://dx.doi.org/10.1002/path.4516.
  33. Suda K., Cruz Diaz L.A., Yoshihara K., Nakaoka H., Yachida N., Motoyama T. et al. Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis. Cancer Sci. 2020; 111(8): 3000-9. https://dx.doi.org/10.1111/cas.14507.
  34. Somigliana E., Infantino M., Candiani M., Vignali M., Chiodini A., Busacca M., Vignali M. Association rate between deep peritoneal endometriosis and other forms of the disease: pathogenetic implications. Hum. Reprod. 2004; 19(1): 168-71. https://dx.doi.org/10.1093/humrep/deg513.
  35. Tosti C., Pinzauti S., Santulli P., Chapron C., Petraglia F. Pathogenetic mechanisms of deep infiltrating endometriosis. Reprod. Sci. 2015; 22(9):1053-9. https://dx.doi.org/10.177/1933719115592713.
  36. Chapron C., Fauconnier A., Vieira M., Barakat H., Dousset B., Pansini V. et al. Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification. Hum. Reprod. 2003; 18(1): 157-61. https://dx.doi.org/10.1093/humrep/deg009.
  37. Gordts S., Koninckx P., Brosens I. Pathogenesis of deep endometriosis. Fertil. Steril. 2017; 108(6): 872-85. e1. https://dx.doi.org/10.1016/j.fertnstert.2017.08.036.
  38. Yong P.J., Bedaiwy M.A., Alotaibi F., Anglesio M.S. Pathogenesis of bowel endometriosis. Best Pract. Res. Clin. Obstet. Gynaecol. 2020; Jun 6: S1521-6934(20)30086-9. https://dx.doi.org/10.1016/j.bpobgyn.2020.05.009.
  39. Anaf V., El Nakadi I., Simon P., Van de Stadt J., Fayt I., Simonart T., Noel J.C. Preferential infiltration of large bowel endometriosis along the nerves of the colon. Hum. Reprod. 2004; 19(4): 996-1002. https://dx.doi.org/10.1093/humrep/deh150.
  40. Lac V., Verhoef L., Aguirre-Hernandez R., Nazeran T.M., Tessier-Cloutier B., Praetorius T. et al. Iatrogenic endometriosis harbors somatic cancer-driver mutations. Hum. Reprod. 2019; 34(1): 69-78. https://dx.doi.org/10.1093/humrep/dey332.
  41. Borrelli G.M., Abrão M.S., Taube E.T., Darb-Esfahani S., Köhler C., Chiantera V., Mechsner S. (Partial) loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes. Mol. Hum. Reprod. 2016; 22(5): 329-37. https://dx.doi.org/10.1093/molehr/gaw009.
  42. Lac V., Nazeran T.M., Tessier-Cloutier B., Aguirre-Hernandez R., Albert A., Lum A. et al. Oncogenic mutations in histologically normal endometrium: the new normal? J. Pathol. 2019; 249(2): 173-81. https://dx.doi.org/10.1002/path.5314.
  43. Anglesio M.S., Papadopoulos N., Ayhan A., Nazeran T.M., Noë M., Horlings H.M. et al. Cancer-associated mutations in endometriosis without cancer. N. Engl. J. Med. 2017; 376(19): 1835-48. https://dx.doi.org/10.1056/NEJMoa1614814.
  44. Bedaiwy M.A., Alfaraj S., Yong P., Casper R. New developments in the medical treatment of endometriosis. Fertil. Steril. 2017; 107(3): 555-65. https://dx.doi.org/10.1016/j.fertnstert.2016.12.025.
  45. Vitale S.G., Capriglione S., Peterlunger I., La Rosa V.L., Vitagliano A., Noventa M. et al. The role of oxidative stress and membrane transport systems during endometriosis: a fresh look at a busy corner. Oxid. Med. Cell. Longev. 2018; 2018: 7924021. https://dx.doi.org/10.1155/2018/7924021.
  46. Sampson J.A. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am. J. Pathol. 1927; 3(2): 93-110.
  47. Keichel S., Barcena de Arellano M.L., Reichelt U., Riedlinger W.F., Schneider A., Köhler C., Mechsner S. Lymphangiogenesis in deep infiltrating endometriosis. Hum. Reprod. 2011; 26(10): 2713-20. https://dx.doi.org/10.1093/humrep/der230.
  48. Fargas F.F., Cusid G.M., Tresserra Casas F., Baulies S., Fabregas R. Malignant transformation of abdominal wall endometriosis with lymph node metastasis: case report and review of literature. Gynecol. Oncol. Case Rep. 2014; 8: 10-3. https://dx.doi.org/10.1016/j.gynor.2013.12.003.

Received 19.11.2020

Accepted 12.01.2021

About the Authors

Shakhnoza K. Muftaydiniva, PhD student, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel.: +7(967)133-42-08. E-mail: shaxnozka_87@mail.ru. 4, Oparina str., Moscow, 117997, Russia.
Natalia A. Buralkina, Dr. Med. Sci., senior researcher, Surgical Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel.: +7(926)405-62-83. E-mail: n_buralkina@oparina4.ru. 4, Oparina str., Moscow, 117997, Russia.
Leonid Z. Faizullin, Cand. Bio. Sci., leading researcher, Laboratory of Molecular Genetic Methods, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel.: +7(916)710-67-89. E-mail: l_faizullin@oparina 4. 4, Oparina str., Moscow, 117997, Russia.

For citation: Muftaydinova Sh.K., Buralkina N.A., Faizullin L.Z. Endometriosis and cancer.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021; 3: 12-17 (in Russian)
https://dx.doi.org/10.18565/aig.2021.3.12-17

Similar Articles

№10 / 2024
Kondratovich L.M., Chursin V.V., Dzhabiev A.V., Chuprynin V.D., Badlaeva A.S.
Heterotopic pregnancy after surgical treatment of colorectal endometriosis
№3 / 2023
Shchegolev M.A., Tumanova U.N., Shchegolev A.I., Khilkevich E.G.
Pregnancy and delivery complications in endometriosis
№11 / 2023
Chernukha G.E., Pronina V.A., Solopova A.E.
Modern possibilities for optimizing the diagnosis and therapy of ovarian endometriomas
№5 / 2023
Chernukha G.E., Pronina V.A.
Prolonged hormonal therapy for endometriosis: how to make the right choice?
№6 / 2024
Chernukha G.E., Solopova A. E., Pronina V.A.
New possibilities for assessing the magnetic resonance characteristics of endometrioid ovarian cysts and their response to dienogest therapy
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.